cfap206 Antibody

What is CFAP206 and what functional roles does it serve in cellular processes?

CFAP206 (Cilia and Flagella Associated Protein 206) is a protein critical for motile cilia and flagella function. Based on current research, it appears to be a target of the transcription factor FOXJ1 and plays an essential role in sperm motility . Similar to other CFAP family members such as CFAP20, it likely contributes to cilium assembly and function. CFAP20, a related protein, has been well-characterized as having a mass of approximately 22.8 kDa with localization in both nucleus and cytoplasm . While CFAP206 differs in structure and specific function, it belongs to the same family of proteins essential for ciliary architecture and motility.

What are the primary research applications for CFAP206 antibodies?

CFAP206 antibodies are primarily utilized in research applications focused on ciliary and flagellar biology. By extrapolating from established applications of related CFAP antibodies, the following methodologies are commonly employed:

The specific applications should be validated for each antibody clone and experimental system, similar to how CFAP20 antibodies have been validated for Western Blot and immunofluorescence applications .

How do researchers confirm CFAP206 antibody specificity?

When validating CFAP206 antibody specificity, researchers should employ multiple complementary approaches:

• Knockout/knockdown validation: Testing antibody on CFAP206 knockout or knockdown samples to confirm absence of signal

• Recombinant protein detection: Using purified CFAP206 protein as positive control

• Preabsorption tests: Pre-incubating antibody with immunizing peptide to demonstrate signal extinction

• Cross-species reactivity assessment: Testing reactivity across relevant model organisms

• Multiple antibody comparison: Using antibodies targeting different epitopes of CFAP206

Specificity testing is particularly critical as CFAP family proteins share structural similarities that could lead to cross-reactivity, as observed with other ciliary proteins like CFAP20, which has multiple orthologs across species including mouse, rat, bovine, frog, zebrafish, and others .

How should researchers optimize CFAP206 antibody protocols when investigating sperm motility?

When investigating CFAP206 in sperm motility studies, several optimization steps are essential:

• Sample preparation: Fresh sperm samples require gentle handling to preserve flagellar structures. Use of specialized fixatives (0.1-0.5% paraformaldehyde) helps maintain structural integrity while enabling antibody access.

• Permeabilization optimization: Titrate detergent concentrations (0.1-0.5% Triton X-100) to maintain membrane permeability without disrupting flagellar architecture.

• Signal amplification: Consider tyramide signal amplification techniques for low abundance proteins.

• Co-localization studies: Pair CFAP206 antibodies with established flagellar markers (acetylated tubulin, SPAG6) to contextually validate localization.

• Functional correlation: Combine immunostaining with computer-assisted sperm analysis (CASA) to correlate CFAP206 localization patterns with motility parameters.

Based on research showing CFAP206's requirement for sperm motility , antibodies targeting this protein are valuable tools for investigating male fertility disorders and fundamental flagellar biology.

What approaches help resolve contradictory results when using different CFAP206 antibody clones?

When faced with contradictory results from different CFAP206 antibody clones, implement the following systematic troubleshooting strategy:

• Epitope mapping analysis: Determine the specific epitopes recognized by each antibody clone and assess whether post-translational modifications or protein interactions might differentially affect epitope accessibility.

• Clone characterization matrix:

• Orthogonal validation: Confirm results using non-antibody methods such as CRISPR/Cas9 gene editing, RNA interference, or mass spectrometry.

• Context-dependent optimization: Adjust protocols based on specific experimental conditions, as antibody performance may vary with different fixation methods, buffer compositions, or incubation parameters.

• Collaborative verification: Engage with other laboratories investigating CFAP206 to compare results with different antibody batches and experimental conditions.

This approach mirrors antibody validation strategies used with other ciliary proteins like CFAP20, where multiple applications require separate optimization protocols .

What considerations are important when selecting fixation methods for CFAP206 immunostaining?

Fixation method selection significantly impacts CFAP206 antibody performance in immunostaining:

Researchers working on related proteins like CFAP20 have found that combining appropriate fixation with specialized permeabilization techniques enhances antibody penetration into complex ciliary and flagellar structures .

How should researchers design experiments to investigate CFAP206's role in ciliary function?

When designing experiments to elucidate CFAP206 function in cilia:

• Model system selection: Choose appropriate models based on experimental questions:

  • Cell lines: hTERT-RPE1, IMCD3 (for primary cilia)

  • Specialized cell types: Multiciliated cells from airway epithelia, ependymal cells

  • Animal models: Zebrafish, mice, Xenopus embryos

• Knockdown/knockout strategy:

  • siRNA/shRNA: For transient, dose-dependent reduction

  • CRISPR/Cas9: For complete protein elimination

  • Conditional systems: For temporal control of gene expression

• Readout selection:

  • Structural analysis: High-resolution imaging (SIM, STED, cryo-EM)

  • Functional assessment: Ciliary beat frequency, fluid flow measurements

  • Protein interaction studies: Proximity labeling, co-immunoprecipitation

• Control implementation:

  • Rescue experiments: Re-expression of wild-type or mutant CFAP206

  • Comparative analysis with known ciliary mutants

  • Parallel assessment of multiple CFAP family members

Based on evidence that CFAP206 is a FOXJ1 target and is required for sperm motility , experimental designs should incorporate motility assessments and potential interactions with FOXJ1-regulated networks.

What controls are essential when using CFAP206 antibodies for protein localization studies?

For rigorous CFAP206 localization studies, implement the following controls:

• Negative controls:

  • Secondary antibody-only control to assess non-specific binding

  • CFAP206 knockout/knockdown samples to confirm signal specificity

  • Pre-immune serum (for polyclonal antibodies) to evaluate background

• Positive controls:

  • Tissues/cells with known CFAP206 expression

  • Recombinant CFAP206-expressing cells

  • Co-staining with established ciliary markers (acetylated tubulin, IFT88, ARL13B)

• Validation controls:

  • Multiple antibodies targeting different CFAP206 epitopes

  • Fluorescent protein-tagged CFAP206 expression

  • Cross-species validation in evolutionary conserved systems

• Technical controls:

  • Titration series to determine optimal antibody concentration

  • Z-stack acquisition to capture complete ciliary structures

  • Time-course analysis for dynamic localization studies

These control strategies parallel those used for other ciliary proteins such as CFAP20, which requires careful validation across multiple applications .

How can researchers quantitatively analyze CFAP206 expression levels from immunoblotting experiments?

For robust quantitative analysis of CFAP206 expression:

• Standardized loading protocol:

  • Equal protein loading (verified by total protein stains)

  • Include housekeeping controls appropriate for experimental condition

  • Consider specialized loading controls for ciliated vs. non-ciliated samples

• Signal quantification approach:

• Normalization strategy:

  • To housekeeping proteins (β-actin, GAPDH)

  • To total protein (Ponceau S, REVERT)

  • To ciliary reference proteins (for ciliary abundance studies)

• Statistical analysis:

  • Perform minimum of three biological replicates

  • Use appropriate statistical tests (t-test, ANOVA) based on experimental design

  • Consider non-parametric tests for non-normally distributed data

This quantitative approach aligns with established methods for analyzing ciliary proteins like CFAP20, which is commonly detected and quantified using Western Blot techniques .

How do researchers investigate CFAP206 interactions with other ciliary proteins?

Investigating CFAP206 protein interactions requires multiple complementary approaches:

• Proximity-based methods:

  • BioID/TurboID: Attaching biotin ligase to CFAP206 to identify proximal proteins

  • APEX2: Peroxidase-based proximity labeling for electron microscopy visualization

  • FRET/FLIM: For direct protein-protein interaction assessment in living cells

• Affinity-based approaches:

  • Co-immunoprecipitation with CFAP206 antibodies under varying stringency conditions

  • Tandem affinity purification with tagged CFAP206 constructs

  • Cross-linking mass spectrometry to capture transient interactions

• Genetic interaction studies:

  • Synthetic lethality screening in model organisms

  • Suppressor/enhancer screens to identify functional relationships

  • CRISPR screening for proteins affecting CFAP206 localization/function

• Structural biology approaches:

  • Cryo-electron tomography of CFAP206-containing complexes

  • In situ structural analysis of CFAP206 within intact cilia

Given CFAP206's role in sperm motility , particular attention should be given to interactions with axonemal dynein regulatory complexes and other components essential for coordinated ciliary beating.

What approaches can researchers use to study CFAP206 in human disease models?

For investigating CFAP206 in human disease contexts:

• Patient-derived samples:

  • Primary cells from patients with suspected ciliopathies

  • Analysis of CFAP206 mutations in male infertility cohorts

  • Immunohistochemical assessment of CFAP206 in ciliopathy tissues

• Disease modeling systems:

• Functional rescue approaches:

  • Complementation with wild-type or mutant CFAP206

  • Small molecule screening for functional restoration

  • Gene therapy approaches in model systems

• Clinical correlation studies:

  • Genotype-phenotype correlations in patient cohorts

  • Analysis of CFAP206 variants in population databases

  • Meta-analysis of ciliopathy sequencing data

Based on CFAP206's requirement for sperm motility , prioritizing male infertility and primary ciliary dyskinesia studies would be particularly informative.

How can researchers assess the impact of CFAP206 post-translational modifications on protein function?

To investigate CFAP206 post-translational modifications (PTMs):

• PTM identification strategy:

  • Mass spectrometry analysis of immunoprecipitated CFAP206

  • Phospho-specific antibodies for known modification sites

  • Proteomic database mining for predicted PTM sites

• Functional assessment of PTMs:

  • Site-directed mutagenesis of modified residues

  • Phosphomimetic and phospho-null mutations

  • Temporal analysis during ciliogenesis or cell cycle

• Regulatory enzyme identification:

  • Kinase/phosphatase inhibitor screening

  • Candidate approach based on ciliary enrichment

  • Proximity labeling to identify modifying enzymes

• Physiological context:

  • Stimulation-dependent modification analysis

  • Cell cycle-dependent regulation

  • Developmental timing of modifications

This approach parallels studies of other CFAP family proteins, where post-translational modifications often regulate assembly, localization, and function within ciliary structures.

How do researchers troubleshoot weak or absent CFAP206 signals in Western blots?

When encountering weak CFAP206 signals in Western blotting:

• Sample preparation optimization:

  • Evaluate protein extraction methods (RIPA vs. gentler lysis buffers)

  • Consider specialized extraction for ciliary/flagellar proteins

  • Test fresh vs. frozen samples for signal integrity

• Technical parameter adjustment:

• Antigen retrieval considerations:

  • Addition of SDS (0.1%) to antibody dilution buffer

  • Heat-induced antigen retrieval for certain epitopes

  • Membrane treatment with 0.2% glutaraldehyde to preserve epitopes

• Protein modification awareness:

  • Test reducing vs. non-reducing conditions

  • Consider deglycosylation treatment

  • Evaluate phosphatase treatment to remove phosphorylations

Similar troubleshooting approaches have been successful with CFAP20 antibodies, which are commonly used in Western Blot applications .

What strategies help optimize CFAP206 immunofluorescence staining in ciliated tissues?

For optimal CFAP206 immunofluorescence in ciliated tissues:

• Tissue preparation considerations:

  • Cryosections vs. paraffin: Cryosections often preserve ciliary antigens better

  • Section thickness: 5-10μm optimal for resolving individual cilia

  • Slide coating: Poly-L-lysine or charged slides to prevent tissue detachment

• Antigen retrieval optimization:

  • Heat-mediated: Citrate buffer (pH 6.0) at 95°C for 15-20 minutes

  • Enzymatic: Light protease treatment (1-5 minutes) for certain fixed tissues

  • Combined: Sequential heat and enzymatic for challenging samples

• Signal enhancement techniques:

  • Tyramide signal amplification for low abundance proteins

  • Multi-layered detection systems (biotin-streptavidin)

  • Sequential antibody application protocol

• Advanced imaging considerations:

  • Super-resolution techniques for sub-ciliary localization

  • Deconvolution for improved signal-to-noise ratio

  • Appropriate mounting media to reduce photobleaching

These approaches can be adapted from successful protocols used with CFAP20 antibodies, which are frequently employed in immunofluorescence applications .